Enavogliflozin for the Management of Patients With Amyloid CardiomyopaThy

Clinical trial NCT07240844 · RECRUITING

Trial details

NCT number: NCT07240844
Sponsor: Seoul St. Mary's Hospital
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Amyloid Cardiomyopathy

Start date: 2026-01-06
Primary completion: 2027-04-29
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.